Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Carol Cox, Louise Mawhinney

Premium

Life Technologies has appointed Carol Cox to senior vice president of external affairs and corporate communications, a newly created position. Cox has served as vice president of investor relations of Life Tech since she joined the company in December 2011. Previously, she was vice president of investor relations at CareFusion and vice president of global corporate communications and investor relations at Barr Pharmaceuticals. She holds a BA in international relations from the University of Virginia.


Louise Mawhinney, formerly chief financial officer of Helicos, has been appointed to chief financial officer of Aratana Therapeutics. She has also held positions as chief financial officer and vice president of Ikonisys and chief financial officer and founding member of eSpendwise. She holds a Master's degree from the University of St. Andrews in Scotland.

The Scan

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.